Skip to main content

. 1960 Sep;44(9):524–536. doi: 10.1136/bjo.44.9.524

ERROR AND DISCOVERY IN FUNDUS DISEASE^{^*}^,^{^†}

I C Michaelson ¹

PMCID: PMC509982 PMID: 13770164

524

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ASHTON N. Vascular changes in diabetes with particular reference to the retinal vessels; preliminary report. Br J Ophthalmol. 1949 Jul;33(7):407–420. doi: 10.1136/bjo.33.7.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
ASHTON N., WARD B., SERPELL G. Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol. 1953 Sep;37(9):513–520. doi: 10.1136/bjo.37.9.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
BECKER B. Diabetic retinopathy. Ann Intern Med. 1952 Aug;37(2):273–289. doi: 10.7326/0003-4819-37-2-273. [DOI] [PubMed] [Google Scholar]
BECKER B., LANG C. A., CHOW B. F. Vitamin B12 excretion and diabetic retinopathy. J Clin Nutr. 1953 Sep-Oct;1(6):417–423. [PubMed] [Google Scholar]
BECKER B., MAENGWYN-DAVIES G. D., ROSEN D., FRIEDENWALD J. S., WINTER F. C. The adrenal cortex and B-vitamins in diabetic retinopathy. Diabetes. 1954 May-Jun;3(3):175–187. doi: 10.2337/diab.3.3.175. [DOI] [PubMed] [Google Scholar]
BERKMAN J., RIFKIN H., ROSS G. The serum polysaccharides in diabetic patients with and without degenerative vascular disease. J Clin Invest. 1953 May;32(5):415–421. doi: 10.1172/JCI102753. [DOI] [PMC free article] [PubMed] [Google Scholar]
CAMPBELL K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. 1951 Jul 14;2(2):48–50. [PubMed] [Google Scholar]
CROSSE V. M., EVANS P. J. Prevention of retrolental fibroplasia. AMA Arch Ophthalmol. 1952 Jul;48(1):83–87. doi: 10.1001/archopht.1952.00920010086012. [DOI] [PubMed] [Google Scholar]
Friedenwald J. S., Owens W. C. Retrolental Fibroplasia in Premature Infants, III: The Pathology of the Disease. Trans Am Ophthalmol Soc. 1951;49:207–234. [PMC free article] [PubMed] [Google Scholar]
GOOD T. A., GOOD R. A., KELLEY V. C., GLICK D. Mucolytic enzyme systems XVI. Factors influencing hyaluronidase inhibitor levels in serum, role of adrenal cortex. Am J Physiol. 1951 Sep;166(3):555–565. doi: 10.1152/ajplegacy.1951.166.3.555. [DOI] [PubMed] [Google Scholar]
HEATH P. Pathology of the retinopathy of prematurity: retrolental fibroplasia. Am J Ophthalmol. 1951 Sep;34(9):1249–1259. doi: 10.1016/0002-9394(51)91859-4. [DOI] [PubMed] [Google Scholar]
JEFFERSON E. Retrolental fibroplasia. Arch Dis Child. 1952 Aug;27(134):329–336. doi: 10.1136/adc.27.134.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
KINSEY V. E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol. 1956 Oct;56(4):481–543. [PubMed] [Google Scholar]
LEISHMAN R. The eye in general vascular disease: hypertension and arteriosclerosis. Br J Ophthalmol. 1957 Nov;41(11):641–701. doi: 10.1136/bjo.41.11.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
PATZ A., EASTHAM A., HIGGINBOTHAM D. H., KLEH T. Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol. 1953 Nov;36(11):1511–1522. [PubMed] [Google Scholar]
RIFKIN H., SOLOMON S., LIEBERMAN S. Role of the adrenal cortex in diabetic retinopathy and nephropathy. Diabetes. 1958 Jan-Feb;7(1):9–14. doi: 10.2337/diab.7.1.9. [DOI] [PubMed] [Google Scholar]
RYAN H. Retrolental fibroplasia; a clinicopathologic study. Am J Ophthalmol. 1952 Mar;35(3):329–342. doi: 10.1016/0002-9394(52)90003-2. [DOI] [PubMed] [Google Scholar]
SZEWCZYK T. S. Retrolental fibroplasia; etiology and prophylaxis. Am J Ophthalmol. 1952 Mar;35(3):301–311. [PubMed] [Google Scholar]

ACTIONS

RESOURCES